Handmade quality · Free shipping over $75 · Explore the atelier

Practical Application of Polygenic Risk Scoring in the Human Embryo Microfluidics She is the founder of

SKU: 8319294020

4.0
USD10.00 USD46.00

Pay in 4 interest-free payments of $2.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

She is the founder of ART Compass

Evidence from human and mouse

Helen O’Neill

Her group has a particular interest in developing in vitro models to support oocyte development from immature stages in domestic species and human

Practical Application of Polygenic Risk Scoring in the Human Embryo Microfluidics She is the founder ofPractical Application of Polygenic Risk Scoring in the Human Embryo DR. NATHAN TREFF Nathan Treff received his PhD in Biochemistry in 2003 and performed postdoctoral fellowships in embryonic stem cell biology and reproductive genetics at the University of Wisconsin and EMD Serono. He is currently the CSO of Genomic Prediction and Reprocare Genetics Scandinavia, Board Certified in Molecular Diagnostics as a High Complexity Laboratory Director, an

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products